Seasonality of main childhood embryonal tumours and rhabdomyosarcoma, France, 2000-2015.


Journal

Cancer medicine
ISSN: 2045-7634
Titre abrégé: Cancer Med
Pays: United States
ID NLM: 101595310

Informations de publication

Date de publication:
04 2023
Historique:
revised: 13 12 2022
received: 22 07 2022
accepted: 03 01 2023
medline: 1 5 2023
pubmed: 3 2 2023
entrez: 2 2 2023
Statut: ppublish

Résumé

Few studies have investigated the seasonal patterns of embryonal tumours. Based on data from the French National Registry of Childhood Cancers, the present study aimed to investigate seasonal variations in embryonal tumour incidence rates by month of birth and by month of diagnosis. The study included 6635 primary embryonal tumour cases diagnosed before the age of 15 years over the period 2000-2015 in mainland France. Assuming monthly variations in incidence rates were homogeneous over 2000-2015, we used a Poisson regression model to test for overall heterogeneity in standardised incidence ratios (SIRs) by month of birth or diagnosis. The seasonal scan statistic method was used to detect monthly excesses or deficits of embryonal tumour cases over the whole study period. The annual reproducibility of the observed monthly variations was formally tested. An overall heterogeneity in incidence rates by month of birth was observed for rhabdomyosarcoma in boys only. Based on the month of diagnosis, a seasonality was evidenced for unilateral retinoblastoma, with a lower incidence rate in the summer (SIR

Identifiants

pubmed: 36726302
doi: 10.1002/cam4.5624
pmc: PMC10134357
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

8789-8803

Informations de copyright

© 2023 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.

Références

Cancer Epidemiol. 2018 Dec;57:7-12
pubmed: 30248472
J Clin Lab Anal. 2021 Oct;35(10):e23981
pubmed: 34462972
Int J Epidemiol. 2020 Oct 1;49(5):1434-1435k
pubmed: 32642766
Acta Ophthalmol Scand. 2003 Aug;81(4):396-8
pubmed: 12859268
Pediatr Blood Cancer. 2012 Feb;58(2):185-90
pubmed: 22021092
Br J Ophthalmol. 1999 Dec;83(12):1320-3
pubmed: 10574806
Neuroepidemiology. 2007;29(1-2):89-95
pubmed: 17925600
J Expo Sci Environ Epidemiol. 2015 Mar-Apr;25(2):182-6
pubmed: 24280682
Paediatr Perinat Epidemiol. 2010 May;24(3):309-18
pubmed: 20415761
Nat Rev Cancer. 2014 Apr;14(4):277-89
pubmed: 24599217
J Clin Oncol. 2009 Jan 20;27(3):365-70
pubmed: 19047282
Cancer Med. 2023 Apr;12(7):8789-8803
pubmed: 36726302
Cancer Res. 1989 Oct 15;49(20):5730-5
pubmed: 2790788
Horm Res Paediatr. 2013;80(6):457-65
pubmed: 24335096
Nat Rev Cancer. 2005 Jun;5(6):481-8
pubmed: 15905853
Environ Health Perspect. 2000 Jun;108 Suppl 3:573-94
pubmed: 10852857
Nat Rev Dis Primers. 2015 Aug 27;1:15021
pubmed: 27189421
Eur J Cancer Prev. 2010 May;19(3):173-81
pubmed: 20361423
Pediatrics. 2015 Sep;136(3):e623-32
pubmed: 26304823
Pediatr Clin North Am. 2015 Feb;62(1):201-23
pubmed: 25435120
Br J Cancer. 1999 Oct;81(3):549-53
pubmed: 10507784
Clin Ophthalmol. 2007 Dec;1(4):431-9
pubmed: 19668520
Cancer Causes Control. 2017 Oct;28(10):1125-1132
pubmed: 28840389
Lancet. 2012 Apr 14;379(9824):1436-46
pubmed: 22414599
Cancer Epidemiol. 2013 Oct;37(5):575-8
pubmed: 23932492
Pediatr Clin North Am. 2015 Feb;62(1):11-25
pubmed: 25435109
Cancer. 2005 Apr 1;103(7):1457-67
pubmed: 15712273
Cancer Epidemiol. 2020 Apr;65:101697
pubmed: 32155583
Hum Genet. 1990 Jan;84(2):155-8
pubmed: 2298450
Proc Natl Acad Sci U S A. 1971 Apr;68(4):820-3
pubmed: 5279523
Cancer Invest. 2001;19(6):630-40
pubmed: 11486706
J Clin Oncol. 2005 Sep 20;23(27):6459-65
pubmed: 16116153
Virusdisease. 2019 Sep;30(3):360-366
pubmed: 31803802
Arch Pathol Lab Med. 2006 Oct;130(10):1454-65
pubmed: 17090187
Environ Res. 2021 Jun;197:111078
pubmed: 33798513
Ann Epidemiol. 2017 Sep;27(9):593-602.e3
pubmed: 28888834
Nat Rev Dis Primers. 2016 Nov 10;2:16078
pubmed: 27830764
Br J Cancer. 2003 May 6;88(9):1358-60
pubmed: 12778061
Am J Epidemiol. 2004 May 1;159(9):843-51
pubmed: 15105177
Paediatr Drugs. 2017 Dec;19(6):577-593
pubmed: 28786082
Int J Environ Res Public Health. 2018 Mar 13;15(3):
pubmed: 29533992
Int J Hyg Environ Health. 2009 Mar;212(2):186-95
pubmed: 18675586
Am J Ophthalmol. 2017 Apr;176:166-173
pubmed: 28131887
J Clin Oncol. 1993 Aug;11(8):1466-77
pubmed: 8336186
Eur J Cancer. 2012 Jul;48(10):1425-33
pubmed: 22357215
Transl Pediatr. 2015 Apr;4(2):67-75
pubmed: 26835363
Br J Cancer. 2008 Oct 7;99(7):1165-9
pubmed: 18766190
Clin Oncol (R Coll Radiol). 2019 Jul;31(7):462-470
pubmed: 30992168
Br J Cancer. 2009 Jan 13;100(1):185-7
pubmed: 19066608
Arch Environ Health. 2004 Jan;59(1):26-30
pubmed: 16053206

Auteurs

Danielle Awounou (D)

Inserm, UMR 1153 Centre of Research in Epidemiology and StatisticS (CRESS), Epidemiology of childhood and adolescent cancers team (EPICEA), Villejuif, France.
Université Paris Cité, Paris, France.

Brigitte Lacour (B)

Inserm, UMR 1153 Centre of Research in Epidemiology and StatisticS (CRESS), Epidemiology of childhood and adolescent cancers team (EPICEA), Villejuif, France.
Université Paris Cité, Paris, France.
French National Registry of Childhood Solid Tumours (RNTSE), CHU Nancy, Nancy, France.

Emmanuel Desandes (E)

Inserm, UMR 1153 Centre of Research in Epidemiology and StatisticS (CRESS), Epidemiology of childhood and adolescent cancers team (EPICEA), Villejuif, France.
Université Paris Cité, Paris, France.
French National Registry of Childhood Solid Tumours (RNTSE), CHU Nancy, Nancy, France.

Sandra Guissou (S)

Inserm, UMR 1153 Centre of Research in Epidemiology and StatisticS (CRESS), Epidemiology of childhood and adolescent cancers team (EPICEA), Villejuif, France.
Université Paris Cité, Paris, France.
French National Registry of Childhood Solid Tumours (RNTSE), CHU Nancy, Nancy, France.

Nathalie Cassoux (N)

Université Paris Cité, Paris, France.
Department of Surgical Oncology, Institut Curie, Paris, France.

François Doz (F)

Université Paris Cité, Paris, France.
SIREDO Centre (Care, Innovation, Research In Pediatric, Adolescent and Young Adult Oncology), Institut Curie, Paris, France.

Christelle Dufour (C)

Department of Paediatric and Adolescent Oncology, Institut Gustave Roussy, Université Paris Saclay, Villejuif, France.

Véronique Minard-Colin (V)

Department of Paediatric and Adolescent Oncology, Institut Gustave Roussy, Université Paris Saclay, Villejuif, France.
Inserm, UMR 1015, Université Paris Saclay, Villejuif, France.

Gudrun Schleiermacher (G)

SIREDO Centre (Care, Innovation, Research In Pediatric, Adolescent and Young Adult Oncology), Institut Curie, Paris, France.

Sophie Taque (S)

Department of Paediatrics, CHU Rennes, Rennes, France.

Arnauld Verschuur (A)

Department of Paediatric Haematology, Immunology and Oncology, Children Hospital of La Timone, APHM, Marseille, France.

Jacqueline Clavel (J)

Inserm, UMR 1153 Centre of Research in Epidemiology and StatisticS (CRESS), Epidemiology of childhood and adolescent cancers team (EPICEA), Villejuif, France.
Université Paris Cité, Paris, France.
French National Registry of Childhood Haematological Malignancies (RNHE), Villejuif, France.

Stéphanie Goujon (S)

Inserm, UMR 1153 Centre of Research in Epidemiology and StatisticS (CRESS), Epidemiology of childhood and adolescent cancers team (EPICEA), Villejuif, France.
Université Paris Cité, Paris, France.
French National Registry of Childhood Haematological Malignancies (RNHE), Villejuif, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH